Showing 2,658 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

NICE issues appraisal consultation documents for three new hepatitis C therapies

Editor's pick
Hepatitis C Trust
30 July 2015
Pharmaceutical industry

Gilead Profit Tops Estimates as Hepatitis C Drug Sales Surge

Editor's pick
Bloomberg
30 July 2015
Hepatitis & HIV

Interferon-free hepatitis treatment is highly effective for people with HIV and HCV co-infection in three studies

News
29 July 2015
Hepatitis C treatment

Merck Targets Toughest Cases to Gain Hepatitis C Foothold

Editor's pick
Bloomberg
29 July 2015
Hepatitis & HIV

Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection

News
29 July 2015
Hepatitis B

China progresses in hepatitis B vaccination, more treatment effort urged

Editor's pick
Xinhua
27 July 2015
Hepatitis C treatment

Georgia sets sights on eliminating hepatitis C

Editor's pick
WHO Europe
27 July 2015
Hepatitis C transmission & prevention

Viral hepatitis – 400 deaths a day in the WHO European Region could be prevented

Editor's pick
WHO Europe
27 July 2015
New & experimental hepatitis C treatment

FDA OK’s BMS Daklinza (Daclatasvir) to Treat Hep C Genotype 3

Editor's pick
AIDSMeds
27 July 2015
New & experimental hepatitis C treatment

FDA approves Technivie for treatment of chronic hepatitis C genotype 4

Editor's pick
FDA
27 July 2015
Hepatitis C treatment

How Sure Is a Cure?

Editor's pick
Poz
20 July 2015
Hepatitis C treatment

Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

Editor's pick
Wall Street Journal Pharmalot blog
20 July 2015
Hepatitis & HIV

Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection

News
20 July 2015
Hepatitis C treatment

Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers

Editor's pick
Wall Street Journal
19 July 2015
Pharmaceutical industry

TAG Pipeline Report

Editor's pick
TAG
17 July 2015
People who inject drugs

Improving access to, and completion of, hepatitis C treatment

Editor's pick
Public Health England
17 July 2015
Hepatitis B

Drug Resistance Common Among European Patients With Chronic Hepatitis B

Editor's pick
Medscape
14 July 2015
New & experimental hepatitis C treatment

Gilead pills priced at $1,000 a day are found cost-effective

Editor's pick
Bloomberg
14 July 2015
New & experimental hepatitis C treatment

Leading Canadian researcher calls for inclusion of co-infected people in large HCV clinical trials

Editor's pick
CATIE
7 July 2015
Access to healthcare

The Medicines Patent Pool Releases Independent Feasibility Studies on Hepatitis C and Tuberculosis

Editor's pick
Medicines Patent Pool
7 July 2015
Hepatitis C symptoms & diagnosis

US: Hepatitis C Rising -- Especially Among Young People -- and May Be Underestimated

Editor's pick
HIVandHepatitis.com
6 July 2015
Hepatitis C symptoms & diagnosis

Public health surveillance system may underestimate cases of acute hepatitis C infection

Editor's pick
Eurekalert Inf Dis
2 July 2015
New & experimental hepatitis C treatment

People with HIV and HCV co-infection who have fibrosis stages F2 and above should be prioritised for new anti-HCV therapies

News
2 July 2015
Hepatitis C treatment

National study finds life-threatening barriers in access to breakthrough drugs

Editor's pick
Eurekalert
30 June 2015